Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 370,000 | 217,000 | 277,000 | 123,000 | 139,000 |
| Receivables | 1,577,000 | 1,828,000 | 1,796,000 | 1,712,000 | 1,621,000 |
| Inventories | 1,628,000 | 1,579,000 | 1,566,000 | 1,300,000 | 1,228,000 |
| Other current assets | 1,043,000 | 880,000 | 1,019,000 | 3,024,000 | 3,083,000 |
| TOTAL | $4,823,000 | $4,699,000 | $4,847,000 | $6,334,000 | $6,234,000 |
| Non-Current Assets | |||||
| PPE Net | 2,098,000 | 2,079,000 | 1,942,000 | 1,820,000 | 1,782,000 |
| Intangibles | 17,491,000 | 18,062,000 | 18,089,000 | 14,937,000 | 14,627,000 |
| Other Non-Current Assets | 5,700,000 | 5,725,000 | 1,879,000 | 1,217,000 | 1,158,000 |
| TOTAL | $25,289,000 | $25,866,000 | $21,910,000 | $17,974,000 | $17,567,000 |
| Total Assets | $30,113,000 | $30,565,000 | $26,756,000 | $24,309,000 | $23,802,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,004,000 | 1,416,000 | 1,297,000 | 1,949,000 | 1,638,000 |
| Accounts payable and accrued liabilities | 605,000 | 542,000 | 512,000 | 524,000 | 498,000 |
| Accrued Expenses | 1,562,000 | 2,109,000 | 1,932,000 | 1,932,000 | 1,963,000 |
| Other current liabilities | 804,000 | 800,000 | 513,000 | 445,000 | 380,000 |
| TOTAL | $3,976,000 | $4,866,000 | $4,254,000 | $4,850,000 | $4,479,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,331,000 | 8,592,000 | 9,590,000 | 7,591,000 | 7,590,000 |
| Other Non-Current Liabilities | 2,412,000 | 2,635,000 | 2,406,000 | 2,027,000 | 2,059,000 |
| TOTAL | $12,332,000 | $11,822,000 | $12,803,000 | $10,034,000 | $10,090,000 |
| Total Liabilities | $16,309,000 | $16,688,000 | $17,057,000 | $14,884,000 | $14,569,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,399,350 | 1,396,195 | 1,393,824 | 1,392,973 | 1,390,653 |
| Common Shares | 16,000 | 16,000 | 16,000 | 16,000 | 16,000 |
| Retained earnings | -2,252,000 | -2,253,000 | -6,249,000 | -6,375,000 | -6,528,000 |
| Other shareholders' equity | 168,000 | 270,000 | 139,000 | 79,000 | 88,000 |
| TOTAL | $13,804,000 | $13,877,000 | $9,699,000 | $9,425,000 | $9,233,000 |
| Total Liabilities And Equity | $30,113,000 | $30,565,000 | $26,756,000 | $24,309,000 | $23,802,000 |